Recently, we demonstrated that DFO and Dp44mT could regulate the Ras/Raf/MEK/ERK cascade by decreasing phosphorylation of ERK1/2 in PC-3 and DU145 prostate cancer cells [120] (Figure 4A). Here, MAPK3 is linked to prostate cancer.